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Space radiation risk quality factors
NASA has derived new models for radiological risk assessment based on epidemiological data and
radiation biology including differences in Relative Biological Effectiveness for leukemia and solid tumors.
Comprehensive approaches were used to develop new risk cross sections and the extension of these
into recommendations for risk assessment during space missions. The methodology relies on published
data generated and the extensive research initiative managed by the NASA Human Research Program
(HRP) and reviewed by the National Academy of Sciences. This resulted in recommendations for revised
speciﬁcations of quality factors, QNASA(Z , β) in terms of track structure concepts that extend beyond
LET alone. The new paradigm for quality factors placed demands on radiation monitoring procedures
that are not satisﬁed by existing dosimetry systems or particle spectrometers that are practical for space
exploration where mass, volume, band width and power consumption are highly constrained. We have
proposed a new deﬁnition of quality factors that relaxes the requirements for identifying charge, Z ,
and velocity, β , of the incident radiation while still preserving the functional form of the inherent risk
functions. The departure from the exact description of QNASA(Z , β) is that the revised values are new
functions of LET for solid cancers and leukemia. We present the motivation and process for developing
the revised quality factors. We describe results of extensive simulations using GCR distributions in free
space as well as the resulting spectra of primary and secondary particles behind aluminum shields and
penetration through water. In all cases the revised dose averaged quality factors agreed with those based
on the values obtained using QNASA(Z , β). This provides conﬁdence that emerging technologies for space
radiation dosimetry can provide real time measurements of dose and dose equivalent while satisfying
constraints on size, mass, power and bandwidth. The revised quality factors are suﬃciently generalized
to be applicable to radiation protection practices beyond space exploration.
© 2014 The Committee on Space Research (COSPAR). Published by Elsevier Ltd.
Open access under CC BY license.1. Introduction
Systems for radiation protection from occupational exposure
to ionizing radiation must include a methodology to optimize
constraints that keep individual exposures as low as reasonably
achievable (ALARA) and insure that the combination of all efforts
will not result in radiation risks that are judged to be unaccept-
able (International Commission on Radiological Protection, 1977).
The ICRP has recognized that the general systems of radiation pro-
tection of workers on earth are not appropriate for astronauts
exposed to environmental radiations during manned space mis-
sions (International Commission on Radiological Protection, 2007;
International Commission on Radiological Protection, 2013). One
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2214-5524 © 2014 The Committee on Space Research (COSPAR). Published by Elsevier Lsigniﬁcant issue is the large contribution of high energy, heavy
charged particles (HZE) which necessitates the determination of ra-
diation quality factors rather than radiation weighting factors, wR .
NASA has established guidance for both acute effects that might
cause performance degradation or sickness resulting from high in-
tensity solar particle events (SPE) and late effects related to the
incidence and possible mortality of cancer from continuous long
term exposure to galactic cosmic rays (GCR). The current permis-
sible exposure limit (PEL) for astronauts corresponds to a 3% risk
of exposure-induced death (REID) evaluated at the 95% conﬁdence
level (NASA, 2007; National Council on Radiation Protection and
Measurements, 2000).
New models for radiological risk assessment have been pro-
posed that include signiﬁcant revisions based on new epidemiolog-
ical data and radiation biology results that indicate RBE differs for
leukemia and solid tumors. Extensive computational approaches
were used to develop new risk cross sections and the extensiontd. Open access under CC BY license.
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missions (Cucinotta et al., 2013). The methodology is based on
published results generated by the comprehensive research pro-
gram that was managed by the NASA Human Research Program
(HRP) which conducts research and develops technologies that al-
low humans to travel safely and productively in the environment
of space.
In 2011, the National Research Council (NRC) Space Science
Board of the National Academy of Sciences began a review of the
NASA Model by a panel of experts in the areas of space physics, ra-
diobiology, epidemiology, and risk assessment. The technical eval-
uation of the NASA model for cancer risks to astronauts due to
space radiation was published in 2012 (National Research Council,
2012).
This resulted in recommendations for revised speciﬁcations of
quality factors, Q , in terms of track structure concepts that ex-
tend beyond LET alone and revised estimates of DDREF. The new
paradigm for determining quality factors places demands on ra-
diation monitoring procedures that are not satisﬁed by existing
dosimetry systems or particle spectrometers suitable for space ex-
ploration. In effect, instrumentation would be required to measure
the charge, Z , and velocity, β , of the complete ﬂuence spectrum
of heavy charged particles in the galactic cosmic ray continuum
Φ(Z , β) generally speciﬁed as dN(Z ,E)dE dΩ dt where dN(Z , E) is the mul-
tiplicity of particle with charge Z and energy E (MeV/n) per cm2
speciﬁed for intervals of energy dE , solid angle dΩ , and time dt .
We have proposed a new deﬁnition of quality factors that re-
laxes the constraint of differentiating charge and velocity while
still preserving the functional form of the inherent risk functions
that are inﬂuenced by relative biological effectiveness and track
structure. The departure from the exact description of Q is that
the revised values are new functions of LET for solid cancers and
leukemia.
We present the motivation and process for developing the new
quality factors and the results of extensive tests using GCR distri-
butions in free space as well as the resulting spectrum of primary
and secondary particles behind aluminum shields and penetration
through water. In all cases the revised dose averaged quality fac-
tors agreed with those based on the values originally proposed
by NASA. This provides conﬁdence that emerging technologies for
space radiation dosimetry can provide real time measurements of
dose and dose equivalent while satisfying constraints on size, mass,
power and bandwidth.
2. Background
To the ﬁrst approximation, there is a phenomenological rela-
tionship between radiation quality and RBE, which is deﬁned in
terms of absorbed dose.
RBE = Dγ
DL
∝ αL
αγ
(1)
where α represents the slope of the linear portion of the dose
response curve for reference photons (γ ) and heavy charged parti-
cles (L).
For convenience in radiation protection, the concept of RBE was
introduced through the quantity of dose equivalent, H , that cor-
relates to the detrimental effects of stochastic late effects. H is
deﬁned as the dose at the point of interest, D , multiplied by an
RBE based Quality Factor, Q (International Commission on Ra-
diological Protection, 1977). This was later modiﬁed to form an
equivalent dose, HT ,R , which is the dose averaged over a tis-
sue or organ, DT , multiplied by a radiation weighting factor, wR
for radiation of type, R (International Commission on Radiologi-
cal Protection, 1990). The ICRP provided a table for recommendedradiation weighting factors for common types of radiation but con-
cluded that for applications in space, where high energy charged
particles contribute signiﬁcantly to the total dose in the human
body, a more realistic approach may have to be used (International
Commission on Radiological Protection, 1990). For mission plan-
ning and operations, NASA uses the model recommended by the
NCRP to estimate cancer risks from space LET-dependent radiation
quality factors, Q (LET) to estimate organ dose equivalents.
Another approach for characterizing radiation quality for pene-
trating charged particles is to introduce risk or action cross sec-
tions, σ , which express the risk per unit ﬂuence (Curtis et al.,
1992; National Council on Radiation Protection and Measurements,
2001). Biophysical models applied to these cross sections provided
a more consistent and accurate description of risks for a large va-
riety of radiations and biological end points (Curtis et al., 1992).
NASA has adopted the biophysical approach and developed a
risk cross section for carcinogenesis, Σ(Z , E), for GCR radiations
with atomic number, Z , and energy per nucleon, E (Cucinotta et
al., 2013).
Σ(Z , E) = Σ0 · P (Z , E) + αγ · LET
6.24
· (1− P (Z , E)), (2)
where
P (Z , E) = (1− e −(Z
∗/β)2
κ
)m · PTD (3)
Z∗ = Z(1− e−(
1.25·β
Z2/3
))
(4)
PTD =
(
1− e−( EETD )) (5)
The parameter m is the slope of the cross section representing the
increase in RBE as the ionization density increases. κ determines
the location of the maximum value of RBE and then begins to de-
cline due to saturation effects of increasing ionization density. The
quantity Z∗ in Eq. (4) represents the reduced charge of the posi-
tive ions as they reach low velocities. PTD takes into consideration
the decrease in the radial dimensions, “thinning down”, of a track
as it nears termination (Katz et al., 1971). ETD (MeV/n) in Eq. (5)
is set at 0.2 based on experimental data for H and He (Cucinotta
et al., 2013).
Ideally, a dosimetric approach and ﬂuence based approach
should provide similar estimates of risk, and thus:
D · Q = Σ · Φ (6)
Considering that:
D = LET
ρ
· Φ (7)
and
RBE = 6.24
αγ · LET (8)
where the units are expressed as D (Gy), LET (keV/μm) and
ρ (g/cm3). One then obtains the following expression for the pro-
posed NASA quality factor:
QNASA =
(
1− P (Z , E))+ 6.24(Σ0/αγ )
LET
· P (Z , E) (9)
This constitutes a hybrid approach where absorbed dose is modi-
ﬁed by a ﬂuence-based biophysical model for QNASA.
Implementation of this approach using Eqs. (3), (4), (5) and
(9) will introduce signiﬁcant challenges to the development of in-
strumentation and data processing. Table 1 is a summary of the
parameters that need to be included either by derivation from the
model or real-time measurements in space. The coeﬃcients can be
applied off line and include values for solid tumors and leukemia,
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Model parameters for QNASA.
Model coeﬃcients Measured quantities
Parameter Units Parameter Units
Σ0/αγ Gy · μm2 D Gy
m – LET keV/μm
κ Z/β E , β MeV/n
ETD MeV/n Z –
DDREF –
Table 2
Parameters for QNASA.
Parameter Solid cancer Leukemia
Z  4 Z > 4 Z  4 Z > 4
m 3 3 3 3
κ (Z/β)2 1000 550 1000 550
Σ0 (μm2) 7000 7000 1750 1750
αγ (Gy−1) 6.24 6.24 6.24 6.24
ETD (MeV/n) 0.2 0.2 0.2 0.2
Fig. 1. QNASA for Solid Cancers as a function of Z∗ 2/β2 for H, He, C, Si, and Fe.
whereas the onboard dosimetry system must supply the measured
parameters for incident charged particles.
Model coeﬃcients were selected to provide quality factors for
solid cancers and leukemia as well as for charged particles with
Z > 4 and Z  4 (Cucinotta et al., 2013). These are summarized in
Table 2.
Fig. 1 shows the values of QNASA for solid cancers as a function
of Z∗ 2/β2 for H, He, C, Si and Fe. The coeﬃcients Σ0/αγ , m, κ and
ETD are nominal values shown in Table 2. QNASA has a maximum
value near 40 for ions with Z < 6 and a peak value near 25 for
Fe. This is a reﬂection of the track structure model where heavy
particles have a larger velocity for a ﬁxed value of Z∗ 2/β2. This
illustrates the complex nature of QNASA since the estimation of Q
requires identiﬁcation of Z and β (e.g., MeV/n).
Fig. 2 shows values of QNASA for solid cancers as a function of
energy per nucleon, E . This illustrates the large dynamic spread in
energies where QNASA is maximum and therefore must be within
the window of sensitivity of the instrumentation.
3. Methodology
We have developed a process to evaluate the implications of
implementing QNASA for typical distributions of GCR, Φ(Z , β), with
using energy per nucleon, E (MeV/n), as the measure of β . OurFig. 2. QNASA for Solid Cancers as a function of Energy per nucleon (MeV/n) for H,
He, C, Si, and Fe.
approach has been to combine the expected GCR ﬂuence, Φ(Z , E),
with QNASA(Z , E) to approximate the proﬁle of dose equivalent,
H(Z , E) with the objective of identifying regions where it would
be possible to relax or compress speciﬁcations for detector require-
ments while focusing on other regions of the spectrum without
compromising risk assessment. This is summarized in the follow-
ing steps:
1) Compute QNASA(Z , E) for the range Z (1 to 26) and MeV/n
(25, 2000).
2) Select a distribution of GCR ﬂuence, Φ(Z , E), for the same
range (GCR O’Neill, 2010; Wilson et al., 1995).
3) Compute the dose delivered from charged particles, D(Z , E) ∼
Φ(Z , E) · LET(Z , E).
4) Compute the dose equivalent from charged particles H(Z , E) ∼
D(Z , E) · QNASA(Z , E).
5) Compute the dose averaged quality factor Q NASA for these con-
ditions.
Where
Q NASA =
∑
Z
∫
E Q (Z , E) · D(Z , E)dE∑
Z
∫
E D(Z , E)dE
(10)
6) Evaluate regions of (Z , E) that have the greatest inﬂuence on
Q NASA.
7) Repeat for additional ﬂuence distributions.
Fig. 3 shows a 3-dimensional surface proﬁle of QNASA for solid
tumors as a function of Z and E . There is no apparent portion of
this proﬁle that vanishes or remains relatively constant.
Results of the computations for Φ , D , H , and Q NASA using GCR
ﬂuence in free space at solar minimum, solar maximum and pene-
tration of solar minimum through 2 cm of aluminum are summa-
rized in Table 3. Although 99% of the ﬂuence for GCR in free space
and penetrating a thin layer of aluminum consists of charged parti-
cles with Z  4, they only contribute to about 50% of the dose and
10% of the dose equivalent for solid cancers. The dose averaged
quality factors are similar for both solar minimum and maximum,
but are reduced by 20% after penetration through the 2 cm of alu-
minum. The values of Q NASA for leukemia are more than a factor of
two less than the values for solid tumors. Light particles contribute
more than 20% of the dose equivalent for leukemia compared with
about 10% for solid cancers.
Fig. 4 shows a surface proﬁle of H(Z , E) for solid cancers
from the GCR spectrum at solar minimum. There is an observable
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Table 3
Results of computations for Φ(Z ,MeV/n), D(Z ,MeV/n), H(Z ,MeV/n) and Q NASA.
GCR Φ D QNASA H Q NASA
Z  4 Z > 4 Z  4 Z > 4 Z  4 Z > 4
Solar max. 99% 1% 50% 50% Solid cancers 7% 93% 7.0
Solar min. 99% 1% 60% 40% 8% 92% 7.0
2 cm Al 99% 1% 70% 30% 14% 86% 5.0
10 cm Al + 20 cm water 99.9% 0.1% 96% 4% 86% 14% 2.2
Solar max. 99% 1% 50% 50% Leukemia 21% 79% 2.4
Solar min. 99% 1% 60% 40% 24% 76% 2.4
2 cm Al 99% 1% 70% 30% 36% 64% 2.0
10 cm Al + 20 cm water 99.9% 0.1% 96% 4% 92% 8% 1.3
Fig. 4. Surface proﬁle of dose equivalent (D · QNASA) in free space for an incident ﬂuence of GCR at solar minimum, Φmin(Z ,MeV/n).increase of H below 100 MeV/n with speciﬁc enhancements for
C, O, Ne, Mg, Si and Fe. However, there are contributions to H
throughout the entire distribution of Z and MeV/n. Integration of
the distributions show that 70% to 80% H(Z , E) is delivered by par-
ticles with energies greater than 100 MeV/n. There did not appearto be any region where charge or velocity could be grouped to re-
lax demands on detector systems.
We have explored another approach to forming a quality factor
suitable for space radiations that eases the demands on dosime-
try systems. The objective was to preserve the functional form of
100 T.B. Borak et al. / Life Sciences in Space Research 1 (2014) 96–102Fig. 5. QNASA for H, He, C, Si, Fe and QNL for solid cancers as a function of LET.
Fig. 6. QNASA for H, He, C, Si, Fe and QNL for leukemia as a function of LET.
Table 4
Coeﬃcients for QNL .
Solid cancers Leukemia
ΣL (keV/μm) 5700 1800
Λ (keV/μm) 70 71
m 3.0 3.5
QNASA but replace (Z∗ 2/β2) in Eq. (9) and Eq. (3) with LET in units
of keV/μm:
QNL (LET) =
(
1− P (LET))+ ΣL
LET
· P (LET) (11)
P (LET) = (1− e− LETΛ )m (12)
The coeﬃcients, ΣL, Λ, and m are new model parameters for QNL
having values shown in Table 4.
Fig. 5 shows a comparison of QNASA and QNL for solid cancers
and Fig. 6 shows the comparison for leukemia. Fig. 7 shows the
surface proﬁle of QNL as a function of Z and MeV/n. This sur-
face proﬁle for QNL preserves the same general shape as that for
QNASA in Fig. 3. However as illustrated in Figs. 5 and 6, QNL has
a smaller peak value at a ﬁxed value of LET for all particles but
broader width compared with QNASA for individual values of Z .
We have performed an evaluation of the dose averaged values
of Q NASA and Q NL from charged particles similar to that outlined
above. For this we have used the code HZETRN (Wilson et al.,
1995; Slaba et al., 2010) to transport the GCR ﬂuence distribu-
tion, Φ(Z , E), at solar minimum through thick aluminum shields
followed by volumes of water. The computations include fragmen-
tation and slowing down as a function of depth in water at the
surface, 1 cm, 5 cm, 10 cm and 20 cm, downstream from 2 cm,
5 cm and 10 cm of aluminum. The computation includes ele-
ments from Z = 1 to Z = 26 and corresponding velocities from
E = 1 MeV/n to E = 50000 MeV/n.
Fig. 8 shows the results for solid cancers and Fig. 9 shows re-
sults for leukemia. In all cases Q NL was within 5% of the values
obtained for Q NASA. These data show that for penetration through
48 g/cm2 of aluminum and water, both Q NL and Q NASA converge
to similar values. In this situation the ﬂuence is strongly domi-
nated by H and He as shown in Table 3. Beyond 50 g/cm2, the
majority of the heavy particles have either stopped or fragmentedFig. 7. Surface proﬁle of QNL for solid cancers as a function of atomic number (Z ) and energy per nucleon E (MeV/n).
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the solar minimum GCR spectrum penetrating various depths in water downstream
from aluminum shields.
into light particles. The composition is almost exclusively H and He
and the quality factors for charged particles remain stable as the
shields become thicker. However, in this regime, the dose and dose
equivalent from directly ionizing charged particles will be dimin-
ished and be dominated by secondary neutrons.
4. Summary
New paradigms for assessing REID for space radiation place
demands on radiation monitoring procedures that are not satis-
ﬁed by existing space ﬂight dosimetry systems or compact particle
spectrometers. The derivation of the proposed quality factors for
the composition of HZE particles in the GCR is based on exten-
sive ground based research over several decades. The amount of
information relating to the physical behavior and biological re-
sponse of heavy high energy particles with a large range of LET
is unprecedented. The results of these efforts have been published
in conference proceedings, peer reviewed literature and vetted in
over 20 annual workshops. The process of consolidating this vast
reservoir of information into risk models and radiation quality fac-
tors has been thorough and reviewed by the National Academy of
Sciences.
However the routine implementation of the recommended
quantities, in particular, radiation quality factors, places severe
demands of radiation dosimetry systems that are necessary for
providing measurements for assessing both dose and dose equiva-
lent.
We have presented an alternate approach to deﬁning quality
factors that does not require identiﬁcation of the charge (Z ) and
E (MeV/n) of the incident radiation. It is based on redeﬁning the
new quality factors as a function of LET, independent of charge
and energy. It certainly can be argued that LET alone is insuﬃcient
to describe the complex nature of biological response to ionizing
radiation. But the process attempts to preserve the functional form
of the new quality factors and differences between risk estimates
for solid cancers and leukemia.
We are also aware that deﬁning quality factors based on LET
is not an original approach. The International Commission of Ra-
diological Protection (ICRP) recommended a function for Q (L) in
Publication 26 (International Commission on Radiological Protec-
tion, 1977) and revised this in Publication 60 (International Com-
mission on Radiological Protection, 1990). Fig. 10 shows these
relationships along with the one suggested here. There is no the-
oretical foundation or phenomenological evidence to suggest that
risk coeﬃcients remain constant for high LET or reach a maximum
point value and transform immediately from a linear relationshipFig. 9. Dose mean Quality Factors (Q NASA and Q NL ) for leukemia resulting from
the solar minimum GCR spectrum penetrating various depths in water downstream
from aluminum shields.
Fig. 10. Quality factors deﬁned by ICRP 26, ICRP 60 and QNL for solid cancers and
leukemia as a function of LET.
into a power function proportional to LET−1/2. As can be seen,
QNL preserves the increase in values from low LET to a maxi-
mum value of 27 at 130 keV/μm followed by a decrease as LET
continues to increase. The departure from ICRP 60 is the sym-
metrical shape of the distribution as opposed to an instantaneous
change in slope. The mathematical form is a continuous differen-
tiable function for all meaningful values of LET. It is argued that
this is a more representative reﬂection of the biophysical processes
based on long standing models and improved scientiﬁc data. The
ICRP quality factors do not distinguish between solid cancers and
leukemia.
Recommendations for radiation protection often need to bal-
ance between ﬁdelity to biophysical processes that control risk
and operational constraints. The goal is to accommodate both ends
of this spectrum without sacriﬁcing reasonable expectations for
demonstrating compliance with optimization and limitation. It is
suggested that this formulation of QNL satisﬁes this goal for as-
tronauts during manned space exploration missions and could be
considered as a revision for quality factors in general.
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